UBS returned 12m shares out of 21m DLS shares it borrowed earlier. Not a good time to be shorting DLS shares!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025